How is a urinary fistula treated following a partial nephrectomy nephron-sparing surgery (NSS)?

1. Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. 2002 Aug. 168(2):454-9. [Medline].

2. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999 Oct. 162(4):1282-4; discussion 1284-5. [Medline].

3. Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. 1999 Sep. 17(9):2868-75. [Medline].

4. Richstone L, Montag S, Ost MC, et al. Predictors of hemorrhage after laparoscopic partial nephrectomy. Urology. 2011 Jan. 77(1):88-91. [Medline].

5. Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, Rogers CG, et al. Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients. BJU Int. 2016 Jan. 117 (1):131-7. [Medline].

6. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000 Feb. 163(2):442-5. [Medline].

7. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006 Sep. 7(9):735-40. [Medline].

8. Licht MR, Novick AC, Goormastic M. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. J Urol. 1994 Jul. 152(1):39-42. [Medline].

9. Kletscher BA, Qian J, Bostwick DG, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol. 1995 Mar. 153(3 Pt 2):904-6. [Medline].

10. Van Poppel H, Bamelis B, Oyen R, Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol. 1998 Sep. 160(3 Pt 1):674-8. [Medline].

11. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000 Dec. 75(12):1236-42. [Medline].

12. Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol. 2000 Feb. 163(2):426-30. [Medline].

13. Dechet CB, Blute ML, Zincke H. Nephron sparing surgery for unilateral renal cell carcinoma: which variables contribute to contralateral recurrence?. J Urol. 1998. 159:169 A.

14. Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology. 2003 Oct. 62(4):641-6. [Medline].

15. Gill IS, Matin SF, Desai MM, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. 2003 Jul. 170(1):64-8. [Medline].

16. Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA. Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol. 2008 Mar. 53(3):514-23. [Medline].

17. Gettman MT, Blute ML, Chow GK, Neururer R, Bartsch G, Peschel R. Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology. 2004 Nov. 64(5):914-8. [Medline].

18. Ficarra V, Bhayani S, Porter J, et al. Predictors of warm ischemia time and perioperative complications in a multicenter, international series of robot-assisted partial nephrectomy. Eur Urol. 2012 Feb. 61(2):395-402. [Medline].

19. Mir SA, Cadeddu JA, Sleeper JP, Lotan Y. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol. 2011 Mar. 25(3):447-53. [Medline].

20. Gill IS, Novick AC, Meraney AM, et al. Laparoscopic renal cryoablation in 32 patients. Urology. 2000 Nov 1. 56(5):748-53. [Medline].

21. Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors. J Urol. 1997 May. 157(5):1852-3. [Medline].

22. Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. 1995 Jan. 45(1):34-40; discussion 40-1. [Medline].

23. Campbell SC, Novick AC, Streem SB, Klein E, Licht M. Complications of nephron sparing surgery for renal tumors. J Urol. 1994 May. 151(5):1177-80. [Medline].

24. Duffey BG, Choyke PL, Glenn G, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004 Jul. 172(1):63-5. [Medline].

25. Gill IS, Hsu TH, Fox RL, et al. Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology. 2000 Aug 1. 56(2):197-200. [Medline].

26. Hafez KS, Novick AC, Butler BP. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol. 1998 Apr. 159(4):1156-60. [Medline].

27. Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Positron emission tomography in urological oncology. J Urol. 1998 Feb. 159(2):347-56. [Medline].

28. Lang EK. Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma. Cancer. 1984 Nov 15. 54(10):2205-14. [Medline].

29. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996 Jun. 155(6):1868-73. [Medline].

30. Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol. 1990 Oct. 144(4):852-7; discussion 857-8. [Medline].

31. Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J Urol. 2000 Feb. 163(2):431-3. [Medline].

32. Russo P. Open partial nephrectomy: an essential contemporary operation. Nat Clin Pract Urol. 2006 Jan. 3(1):2-3. [Medline].

33. Steinbach F, Novick AC, Zincke H, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. 1995 Jun. 153(6):1812-6. [Medline].

34. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001 Jul. 166(1):6-18. [Medline].

35. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol. 1995 Dec. 154(6):2010-4; discussion 2014-5. [Medline].

36. Zincke H, Ghavamian R. Partial nephrectomy for renal cell cancer is here to stay--more data on this issue. J Urol. 1998 Apr. 159(4):1161-2. [Medline].

37. Kunath F, Schmidt S, Krabbe LM, Miernik A, Dahm P, Cleves A, et al. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. Cochrane Database Syst Rev. 2017 May 9. 5:CD012045. [Medline].

38. Greco F, Autorino R, Altieri V, Campbell S, Ficarra V, Gill I, et al. Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes. Eur Urol. 2019 Mar. 75 (3):477-491. [Medline].

Reza Ghavamian, MD Professor of Clinical Urology, Albert Einstein College of Medicine; Director of Urologic Oncology, Director of Minimally Invasive and Robotic Urologic Surgery, Montefiore Medical Center

Reza Ghavamian, MD is a member of the following medical societies: American Urological Association, Society of Urologic Oncology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Bradley Fields Schwartz, DO, FACS Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, Society of University Urologists

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: AUA Journal of Urology<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cook Medical; Olympus, .

Michael Grasso, III, MD Professor and Vice Chairman, Department of Urology, New York Medical College; Director, Living Related Kidney Transplantation, Westchester Medical Center; Director of Endourology, Lenox Hill Hospital

Michael Grasso, III, MD is a member of the following medical societies: American Medical Association, American Urological Association, Endourological Society, International Society of Urology, Medical Society of the State of New York, National Kidney Foundation, Society of Laparoendoscopic Surgeons

Disclosure: Received consulting fee from Karl Storz Endoscopy for consulting.